Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Asia Deal Watch: Lupin Signs Up Three EU Marketing Partners For NaMuscla

Jun 15 2020

• By Ian Haydock, Anju Ghangurde, Vibha Ravi, and Joseph Haas

Asia Deal Watch

Related Content

Lupin Gears For Europe Specialty Push With Orphan NaMuscla

Oct 22 2018

Deal Watch: BMS To Tap Early-Stage Breakthroughs In Partnership With BioMotiv

Sep 06 2019

Cipla Backs Start-Up As It Builds Digital Health Strategy

Feb 20 2019

Asia Deal Watch: Shionogi Finds Commercial Partners For Symproic In US, Europe

Apr 23 2019

Lupin Optimistic On Albuterol Given COVID-19 Demand

Jun 02 2020

Coronavirus Vaccine JV Gives Refana Option For Panacea Stake

Jun 12 2020

Biopharmas Manage To Deal During Pandemic

Jun 09 2020

Roche, Sanofi Double Down On Post-Coronavirus China With Oncology Alliances

Jun 10 2020

Celltrion Expands In APAC, Small Molecules Via $278m Takeda Asset Buy

Jun 11 2020

Cipla Propels Lung Leadership Plans, Reimagines Operating Models

May 19 2020

Deal 2: Lupin snaps up Temmler's products

Jul 24 2015

Deal Watch: United Therapeutics Looks To Extend PAH Dominance With Respira's Combo Product

Apr 13 2017

Dr Reddy’s Joins Remdesivir Licensees

Jun 15 2020

Related Companies

Lupin Limited

Insud Pharma

Cipla Limited

Debiopharm S.A.

Takeda Pharmaceutical Co. Ltd.

Finch Therapeutics Group, Inc.

Merck KGaA

PharmaMar, S.A.

TTY Biopharm Company Limited

Johnson & Johnson

Dr. Reddy's Laboratories Ltd.

Gilead Sciences, Inc.

Panacea Biotec Ltd.

Celltrion, Inc.

Sanofi

Roche Holding AG

Additional Topics

Asia Pacific Deals Business Strategies M & A Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window